Efficacy and safety of abiraterone acetate in an elderly patient subgroup (aged 75 and older) with metastatic castration-resistant prostate cancer after docetaxel-based chemotherapy - Mulders, P F; Molina, A; Marberger, M (Eur Urol, 2014)
et al.